{"acute myeloid leukaemia": 22.24, "anaemia": 29.95, "angioedema": 2.39, "asthenia": 2.51, "blood creatinine increased": 2.03, "carbohydrate antigen 125 increased": 106.36, "disease progression": 2.98, "drug intolerance": 2.31, "drug resistance": 9.52, "dyspnoea exertional": 2.94, "haematotoxicity": 25.99, "haemoglobin abnormal": 30.2, "haemoglobin decreased": 6.66, "leukopenia": 8.8, "lymphopenia": 6.99, "malignant neoplasm progression": 16.69, "metastases to bone": 9.63, "metastases to central nervous system": 10.53, "metastases to liver": 16.15, "metastases to lung": 8.02, "metastases to lymph nodes": 14.14, "myelodysplastic syndrome": 86.78, "myelosuppression": 13.32, "neutropenia": 6.81, "neutrophil count decreased": 2.26, "off label use": 3.73, "ovarian cancer recurrent": 179.53, "pancytopenia": 6.78, "platelet count decreased": 3.39, "pneumonitis": 5.91, "product use in unapproved indication": 5.22, "prostatic specific antigen increased": 7.09, "red blood cell count decreased": 6.75, "thrombocytopenia": 9.8, "toxicity to various agents": 3.44, "white blood cell count decreased": 4.13}